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Background: According to current evidence, the prevention of obesity should start early in life. Even the prenatal
environment may expose a child to unhealthy weight gain; maternal gestational diabetes is known to be among
the prenatal risk factors conducive to obesity. Here we report the effects of antenatal dietary and physical activity
counselling on pregnancy and infant weight gain outcomes.
Methods: The study was a non-randomised controlled pragmatic trial aiming to prevent childhood obesity, the
setting being municipal maternity health care clinics. The participants (n = 185) were mothers at risk of developing
gestational diabetes mellitus and their offspring. The children of the intervention group mothers were born
between 2009 and 2010, and children of the control group in 2008. The intervention started between 10–17
gestational weeks and consisted of individual counselling on diet and physical activity by a public health nurse, and
two group counselling sessions by a dietician and a physiotherapist. The expectant mothers also received a written
information leaflet to motivate them to breastfeed their offspring for at least 6 months. We report the proportion of
mothers with pathological glucose tolerance at 26–28 weeks’ gestation, the mother’s gestational weight gain
(GWG) and newborn anthropometry. Infant weight gain from 0 to 12 months of age was assessed as weight-for
-length standard deviation scores (SDS) and mixed effect linear regression models.
Results: Intervention group mothers had fewer pathological oral glucose tolerance test results (14.6% vs. 29.2%;
95% CI 8.9 to 23.0% vs. 20.8 to 39.4%; p-value 0.016) suggesting that the intervention improved gestational glucose
tolerance. Mother’s GWG, newborn anthropometry or infant weight gain did not differ significantly between the
groups.
Conclusion: Since the intervention reduced the prevalence of gestational diabetes mellitus, it may have the
potential to diminish obesity risk in offspring. However, results from earlier studies suggest that the possible effect
on the offspring’s weight gain may manifest only later in childhood.
Trial registration: Clinical Trials gov: NCT00970710
Keywords: Childhood obesity, Gestational diabetes mellitus, Diet, Physical activity, Intervention, Prevention* Correspondence: taina.mustila@fimnet.fi
1Seinäjoki Central Hospital, Hanneksenrinne 7, 60220 Seinäjoki, Finland
Full list of author information is available at the end of the article
© 2013 Mustila et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Mustila et al. BMC Pediatrics 2013, 13:80 Page 2 of 11
http://www.biomedcentral.com/1471-2431/13/80Background
The increase in obesity prevalence in recent decades and
the fact that obesity is difficult to reverse, even in child-
hood, has led to the conclusion that the prevention of
obesity is the most effective way to combat this major
health problem [1]. Obesity tends to originate in early
life: nearly 11.3% of 2-year-old girls and 6.3% of boys of
the same age in Finland are overweight or obese and,
according to recently reported prevalence data, nearly
19% of 12–24 month-old children in the USA are obese
[2,3]. The majority of obese pre-schoolers become obese
schoolchildren and adults, which leads to an increased
risk of cardiovascular diseases in adulthood [4,5].
Causes of obesity in pre-schoolers are multifactorial.
Known modifiable risk factors in early life are mother’s
obesity before pregnancy, as well as excessive weight
gain, impaired glucose tolerance and smoking during
pregnancy [6-11]. Moreover, the type of infant feeding,
sleep duration and rapid weight gain during the first year
of life are known risk factors for childhood obesity
[12-18]. High birth weight and ponderal index (weight in
kilograms divided by length in metres cubed, kg/m3)
have been shown to have some effect on subsequent obes-
ity risk, but evidence is weak [19,20]. Mother’s gestational
diabetes (GDM) appears to increase the risk of obesity in
offspring, even if the birth weight is normal [19,21].
Preventive efforts should start in early life. Pragmatic tri-
als are needed to find an effective preventive programme
that is applicable in existing health care settings [22]. Preg-
nant mothers and families with a preschool age child are
often receptive to counselling on the health and well-
being of their offspring. These families are easy to reach
by primary health care. The offspring adopt dietary prefer-
ences during early life even via flavour in amniotic fluid
and breast milk [23,24]. Dietary and physical activity
habits are adopted during the preschool years [25,26]. To
improve the cost-effectiveness of a programme that is car-
ried out in a health care system, it should target families at
risk of having obese offspring. One such risk group is the
offspring of mothers at risk of developing GDM [19,21].
Mothers who are overweight or obese, those who have
had gestational diabetes or a macrosomic newborn in a
previous pregnancy, or those with an immediate family
history of diabetes are considered to be at risk of GDM.
These mothers often have a genetic predisposition to
obesity and type −2 diabetes, which they may pass on to
their offspring.
To the best of our knowledge there are no published
intervention studies starting during the first trimester of
pregnancy and aiming primarily at the prevention of
overweight in the offspring. Only a few obesity preven-
tion programmes targeting infancy have been reported,
and they have mostly had short intervention and follow-
up periods [27,28]. Some of these have shown a positiveeffect on children’s weight development [27-31]. Diet and
physical exercise counselling targeting mothers during the
infant’s first year seemed to result in slower weight gain in
the offspring by the age of four years in a pilot study [29],
while the same intervention during pregnancy did not sig-
nificantly reduce the offspring’s weight gain [32]. Gillman
et al. showed that treating mild GDM had no effect on the
offspring’s weight status by the age of 4–5 years [33]. In
the follow-up of the HAPO Study, glucose levels during
pregnancy were not found to correlate significantly with
offspring’s weight gain until two years of age [34].
The evidence from the obesity prevention programmes
reported has shown that multifaceted intervention is more
effective than targeting a single behaviour [35,36]. A re-
cent meta-analysis of gestational interventions concluded
that the evidence was low to very low for preventing gesta-
tional diabetes, but dietary and lifestyle interventions in
pregnancy can reduce maternal GWG and improve out-
comes for both mother and baby [37].
In this article we report the first results of an ongoing
multifaceted controlled lifestyle intervention trial intended
to prevent childhood obesity (The VACOPP, Vaasa Child-
hood Obesity Primary Prevention, Study) [38]. The study
is being implemented in maternity and child health care
clinics in the city of Vaasa in Western Finland. The inter-
vention started during the first trimester of pregnancy and
first targeted pregnant mothers at maternity health care
clinics and then families until the offspring’s age of five
years. In this paper we report the intermediate outcomes
of the intervention given during pregnancy, such as the
prevalence of GDM, mother’s GWG, newborn weight and
infant weight gain in the groups.
Methods
Design and participants
The study was a non-randomised controlled clinical trial.
All eight municipal maternity and 14 child health care
clinics in the city of Vaasa in Western Finland participated
in the recruitment and intervention. The intervention
group mothers were recruited among the GDM risk group
who were pregnant between February 2009 and April
2010; their offspring comprise the intervention target chil-
dren. The control group was recruited among GDM risk
group mothers and their offspring born in 2008 before the
offspring had reached the age of one year.
The mothers who fulfilled the following criteria were
considered to be at risk of GDM: body mass index (BMI)
≥25 kg/m2, macrosomic newborn (weight ≥4500 g) or
GDM in any previous pregnancy, an immediate family his-
tory of diabetes and/or age ≥40 years. In Finland this
group of mothers is routinely offered an oral glucose toler-
ance test (OGTT) when 26–28 weeks pregnant. The chil-
dren of these mothers were the primary target of the
intervention. Mothers with multiple pregnancy, who were
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psychiatric problems were excluded from the study.
Public health nurses (PHN) recruited the intervention
group in maternity health care clinics at the first personal
contact not later than 12th gestational week, and provided
the expectant mothers with written information about the
research and consent forms. The children of the interven-
tion group mothers were born in 2009 or 2010. The con-
trol group was recruited among mothers who had
undergone OGTT in mid-pregnancy because of a risk of
GDM according to the above mentioned criteria. The con-
trol mothers gave birth in 2008 (January – December).
The control group mothers were identified from the la-
boratory register for maternity care. The research nurses
contacted them by telephone in 2009 requesting their per-
mission to send them written information on the research
and consent forms. All mothers recruited were offered an
opportunity to address questions about the trial by tele-
phone or e-mail to either the research nurse or the re-
searchers. Informed written consent was provided by all
participant mothers prior to the baseline assessments.
In our study power calculations were not primarily
calculated, since the project was intended to pilot an ap-
proach of pragmatic design to the early prevention of
childhood obesity. Power calculations based on mean
BMI z-score in the control group would probably be in-
accurate [39]. Ethical approval for the study was granted
by the Ethics Committee of Vaasa Hospital District.
Intervention
The ante-natal intervention consisted of two group coun-
selling sessions, during the first and second trimesters of
pregnancy. Sessions lasting 1.5 hours were given by a
trained physiotherapist and a dietician working in public
health care. Counselling on diet especially emphasised the
recommended consumption of fibre, energy content, qual-
ity of carbohydrates and fat in the diet [40]. During coun-
selling sessions the expectant mothers received information
on suitable and sufficient exercise during pregnancy. They
also participated in a brief session of muscle tone exercise
that could be repeated at home. Mothers were advised to
exercise for at least 2.5 hours/week (until at least slightly
out of breath) and to do muscle tone training twice a week
[41]. Information about the effect of a healthy diet, exercise
and appropriate weight gain during pregnancy on the
risk of contracting GDM, offspring’s perinatal problems
and obesity in the offspring was given to the participant
mothers. Written educational material on a healthy diet
and physical activity during pregnancy was distributed dur-
ing the sessions. These counselling sessions followed a
structured schema and thus all mothers received the same
information from the dietician and the physiotherapist.
During the 13 routine visits to the maternity health
care clinics starting from tenth week of pregnancy, thePHNs briefly recapped the counselling information pro-
vided during the group sessions. According to the nature
of the pragmatic trials the counselling offered by PHNs
may have varied in content and the time spent on it.
Pragmatic trial counselling should also be tailored
according to the client’s needs. At the first home visit to
the mother and baby the PHN gave mother an informa-
tion leaflet recommending breastfeeding until six
months of child’s age to promote appropriate weight
gain in the infant. The intervention is described in more
detail in the protocol article [38].
Outcome measures
The secondary outcomes of the VACOPP Study until
child’s age of one year are described in this report. The
primary outcome will be BMI and proportion of over-
weight or obese children at the age of six years [38]. Ma-
ternal outcomes were self-reported duration of exercise
(until at least slightly out of breath) during the second and
the third trimesters of pregnancy, OGTT results at 26–28
weeks’ gestation, and GWG until 37 weeks of pregnancy.
The GWG was assessed at 37 weeks’ gestation to ascertain
the most recent weight in the maternity clinic as compre-
hensively as possible for all mothers, and also because
later in pregnancy weight may be greatly affected by swell-
ing. The OGTT was performed with a 75 gram glucose
load. The plasma glucose values were analysed from capil-
lary plasma samples at Vaasa Central Hospital laboratory.
The following OGTT cut-off levels were used for capillary
plasma glucose: 0 h ≥ 5.3 or 1 h ≥ 11.0 or 2 h ≥ 9.6 mmol/l
[42]. The OGTT was considered abnormal if one of those
values exceeded the cut-off level. Neonatal outcomes were
the proportion of non-complicated vaginal deliveries, birth
weight, newborn ponderal index and large- or small-for
-gestational age status. Infant outcomes reported here are
the duration of exclusive breastfeeding, differences in
weight-for-length SDSs and changes in weight-for-length
SDSs at 0, 4, 6 and 12 months of age. We also report the
absolute BMI differences in the groups, and the propor-
tions of overweight and obese infants (overweight reaching
or exceeding +10% and obese reaching or exceeding + 20%
curves for weight-for-length above the mean weight-for
-height of healthy Finnish children) according to the new
Finnish growth reference [43]. These weight-for-length/
height curves with percentual deviation of the mean are
widely used in Finnish health care. The educational level
of parents is defined as follows: “low” corresponds to edu-
cation up to vocational school; “medium” indicates a poly-
technic degree and “high” a university degree.
Data collection
Mothers’ weight was measured to the nearest 0.1 kg in
light clothing on a standard electronic scale by maternity
health care clinic PHNs. Maternal BP (blood pressure)
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monitor (Omron M6) under standard conditions with
two repeated measurements. Mother’s weight gain, BP,
mother’s own estimate on her weekly physical exercise
during pregnancy, and the results of 2-hour 75 gram
OGTT at 26–28 weeks of pregnancy were recorded in
the questionnaires. The questionnaires were completed
partly by the PHN and partly by the mothers during the
first, second and third trimesters of pregnancy during
the intervention group mothers’ visits to maternity
health care. The PHN measured and wrote down the
intervention group physical and laboratory measures for
the questionnaires. Newborn anthropometry was mea-
sured at the hospital by a hospital nurse immediately
after delivery and the study questionnaires were com-
pleted by the PHN at the first visit to maternity care
after delivery.
The control group’s measures during pregnancy were
entered in the questionnaires by the mothers themselves
1–12 months after the end of pregnancy in 2008. The
control mothers transferred data concerning physical
measures and OGTT results to the study questionnaires
from their maternity cards, which were filled in by a
PHN during their pregnancy. The researcher was able to
check the OGTT results from the laboratory register if
necessary. Fathers’ and grandparents’ anthropometry,
possible diabetes diagnose and educational levels were
reported by the participating mothers in both groups.
Child health care clinic PHNs weighed and measured
the infants at routine visits at 4, 6 and 12 months. The
infant’s weight was measured to the nearest 0.01 kg
without clothing on a standard electronic scale. Infants’
length was measured in recumbent position to the
nearest millimetre with a standard stadiometer. Both
intervention and control group infant anthropometric
measures were completed on the questionnaires by the
PHN at the one-year visit to the child health care clinic.
Long-term illnesses affecting growth (e.g. severe food al-
lergies) and duration of exclusive breastfeeding (months)
were likewise recorded in this questionnaire.
Statistical methods
Characteristics of the study participants are described
using means or frequencies and 95% confidence intervals
(Tables 1, 2 and 3). Corresponding 95% confidence inter-
vals (CI) for continuous variables were calculated using
formula mean ± (1.96 * standard error of the mean) and
for categorical variables using the Wilson score method
without continuity according to Newcombe [44]. Differ-
ences between groups were evaluated using Student’s
t-test or Mann–Whitney U-test for normally or non-
normally distributed continuous variables. Normality
was evaluated with the Kolmogorov-Smirnov test. Cat-
egorical variables were tested using the chi-squaretest or Fisher’s exact test. The child’s weight gain was
analysed using weight and length converted to weight-
for-length and their SDSs (z-scores) according to the
recently updated Finnish growth reference [43]. To in-
vestigate the effect of the intervention on child’s weight,
the outcome variable was the child’s weight-for-length
z-score at 0, 4, 6 and 12 months of age. In order to take
into account the within-child correlation between re-
peated measures, we used a multilevel mixed-effects lin-
ear regression models to analyse the association of the
weight-for-length z-score over time by group (interven-
tion/control). The model included a variable (group) to
indicate the difference between groups at baseline and
a variable (time) to indicate the changes of weight-
for-length z-scores over time. The difference in the
change in z-scores across the intervention between the
two groups was tested using an interaction term between
group and time, which can be viewed as the intervention
effect. In addition, we added potential confounding vari-
ables to the model: mother’s education, number of preg-
nancies, smoking status during pregnancy, pre-pregnancy
BMI, gender of the child and target height. None of these
variables were significant, thus the final model only in-
cludes the three factors mentioned above. The goodness-
of-fit of the model was evaluated by normal probability
and residual plots and also tested by the normality of the
residuals (Kolmogorov-Smirnov test). All analyses were
performed using STATA software (version 12.0 for Win-
dows), StataCorp LP, Texas, USA.
Results
The study flow is described in Figure 1. Roughly 700 hun-
dred women per year give birth in the city of Vaasa.
According to the birth registry for 2009 about one third of
women in Finland are at least overweight before preg-
nancy contributing to the risk group of GDM. We
analysed baseline characteristics that might interfere with
offspring’s weight development and found no statistically
significant differences between the groups (Table 1). Of
the intervention group mothers 84/96 (87.5%) participated
in the first trimester counselling sessions held by a diet-
ician and a physiotherapist, and 57/96 (59.4%) in the cor-
responding session during the second trimester. The
participation rate with regard to the PHN counselling was
close to 100% since the counselling was held during rou-
tine visits to the maternity health care clinics.
No statistically significant differences were found in
the weekly duration of pregnant mothers’ exercise dur-
ing the second and the third trimesters of pregnancy or
in GWG until 37 gestational weeks (p-value 0.11)
(Table 2). We also analysed the weight gain in groups in
relation to pre-pregnancy BMI according to IOM:
mothers keeping within the recommended total weight
gain range, mothers below it and mothers exceeding the
Table 1 Baseline characteristics of the trial groups (mean or frequency and 95% CI)
Intervention Control p-value Missing (n in groups)
N 96 89
Age of mother before pregnancy (years) 30.9 (29.7 to 32.0) 30.1 (29.0 to 31.2) 0.37 a -
Mother’s education 0.82 c -
Low 32.3% (23.8% to 42.2%) 28.1% (19.8% to 38.2%)
Medium 43.8% (34.3% to 53.8%) 46.1% (36.1% to 56.4%)
High 24.0% (16.6% to 33.4%) 25.8% (17.8% to 35.8%)
Father’s education 0.27 c 1, 4
Low 34.7% (25.9% to 44.7%) 35.3% (26.0% to 45.9%)
Medium 36.8% (27.8% to 46.8%) 45.9% (35.7% to 56.4%)
High 28.4% (20.3% to 38.2%) 18.8% (11.9% to 28.4%)
Mother’s pre-pregnancy BMI (kg/m2) 27.5 (26.6 to 28.5) 26.6 (25.7 to 27.4) 0.15 a -
Proportion of obese mothers (BMI≥ 30 kg/m2) 26.0% (18.3% to 35.6%) 19.1% (12.3% to 28.5%) 0.26 c -
Father’s BMI (kg/m2) 27.3 (26.5 to 28.1) 27.1 (26.2 to 28.0) 0.86 b 2, 6
Proportion of obese fathers (BMI≥ 30 kg/m2) 20.2% (13.3% to 29.4%) 16.9% (10.3% to 26.4%) 0.57 c 2, 6
Mother, Type −2 Diabetes 0.0% (0.0% to 3.9%) 1.1% (0.2% to 6.1%) 0.48 d 1, 0
Father, Type −2 Diabetes 1.1% (0.2% to 5.8%) 1.1% (0.2% to 6.2%) 1.00 d 2, 2
Proportion of obese grandparent (BMI≥ 30 kg/m2) 56.8% (46.4% to 66.7%) 63.1% (52.4% to 72.6%) 0.40 c 8, 5
Proportion of a grandparent having type −2 Diabetes 39.1% (29.8% to 49.3%) 43.2% (33.0% to 54.1%) 0.59 c 4, 8
Parity 0.24 c -
Primiparous 57.3% (47.3% to 66.7%) 43.8% (35.0% to 55.3%)
Second pregnancy 26.0% (18.3% to 35.6%) 32.6% (23.7% to 42.9%)
At least third pregnancy 16.7% (10.5% to 25.4%) 23.6% (15.0% to 32.2%)
History of newborn >4500 g 2.1% (0.6% to 7.4%) 3.4% (1.2% to 9.4%) 0.60 c 1, 0
Mother smoking during pregnancy 5.2% (2.2% to 11.6%) 11.2% (6.2% to 19.5%) 0.13 c -
Mother’s physical activity (hours/week) during first trimester
of pregnancy (before intervention)*
4.5 (3.9 to 5.1) 4.7 (3.8 to 5.6) 0.41 b 2, 5
a Independent Samples T-test, b Mann–Whitney U-test, c Chi-Square Test, d Fisher’s Exact Test.
BMI = body mass index; CI, confidence interval; *level of at least slightly out of breath.
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recommended range in the intervention group was
43.6% and in the control group 47.2%, but the difference
was not statistically significant (p-value 0.83). The differ-
ences in the proportions of mothers keeping within or
below the recommendations were also not significant be-
tween the groups (data not shown). We further analysed
the association of exceeding GWG recommendations and
pathological OGTT result and did not find it to be statisti-
cally significant (p-value 0.097, data not shown).
The control group mothers had a significantly higher
proportion of abnormal OGTT results than the inter-
vention group (29.2% vs. 14.6%, p-value 0.016). The pro-
portion of mothers having a non-complicated delivery
was similar in both groups. Nor was there significant
difference in the newborn anthropometry (birth weight,
ponderal index, large-for-gestational age status, or small-
for-gestational age status). No significant differences were
found between the groups for the mothers’ pregnancy BPlevel, the proportion of mothers gaining less weight than
recommended, the duration of pregnancies or the small-
for-age status of newborns. Nor was there any significant
difference in the proportions of infants with slow weight
gain. We interpreted the above-mentioned results as indi-
cations of the safety of the intervention.
Duration of exclusive breastfeeding did not differ sta-
tistically significantly between the groups (p-value 0.52)
(Table 2). In addition, no statistically significant differ-
ences were found in length-for-age SDS, weight-for-age
SDS, or weight-for-length SDS at 0, 4, 6 and 12 months
of age between the groups (all data not shown). Propor-
tions (expressed as percentage value deviation from the
mean weight-for-length value according to Finnish defin-
ition of preschool-age overweight and obesity) of over-
weight (≥ + 10% weight-for-length) or obese (≥ + 20%
weight-for-length) infants at ages 4, 6 and 12 months
were not significantly different between the groups, al-
though a slight tendency for the control group to have a
Table 2 Secondary maternal and neonatal outcomes in the trial groups (mean or frequency and 95% CI)




Systolic blood pressure (mmHg) 119.1 (116.9 to 121.2) 116.5 (114.3 to 118.7) 0.10 a 4, 5
Diastolic blood pressure (mmHg) 73.9 (72.4 to 75.4) 72.1 (70.0 to 74.1) 0.14 a 4, 5
Second trimester
Systolic blood pressure (mmHg) 116.8 (114.7 to 119.0) 117.7 (115.4 to 119.9) 0.59 a 2, 6
Diastolic blood pressure (mmHg) 71.7 (70.1 to 73.3) 70.5 (68.5 to 72.5) 0.33 a 2, 6
Physical exercise (h/week)* 4.2 (3.6 to 4.7) 4.5 (3.6 to 5.4) 0.62 b 2, 5
OGTT (Gestational weeks 26–28)
Fasting-0 h (mmol/l) 4.8 (4.7 to 4.8) 4.9 (4.8 to 5.0) 0.12 b -
1 h (mmol/l) 8.7 (8.4 to 9.0) 9.0 (8.7 to 9.4) 0.21 a -
2 h (mmol/l) 6.8 (6.6 to 7.1) 6.9 (6.6 to 7.1) 0.77 a -
Pathological OGTT result (cP) 14.6% (8.9% to 23.0%) 29.2% (20.8% to 39.4%) 0.016c
Third trimester
Systolic blood pressure (mmHG) 122.4 (120.1 to 124.6) 122.5 (120.0 to 125.0) 0.79b 3, 4
Diastolic blood pressure (mmHG) 77.8 (76.1 to 79.5) 75.2 (73.2 to 77.3) 0.052a 3, 4
Physical exercise (h/week)* 3.4 (3.0 to 3.8) 3.2 (2.5 to 3.9) 0.11b 4, 4
Gestational weight gain until 37 gw (kg) 11.4 (10.4 to 12.5) 12.7 (11.5 to 14.0) 0.11a 2, 0
Min – Max −4.9 to 27.2 −1.0 to 34.7
Neonatal
Non-complicated vaginal delivery 77.1% (67.7% to 84.4%) 75.3% (65.4% to 83.1%) 0.77c -
Gestational age at birth 39.8 (39.4 to 40.1) 39.4 (39.2 to 39.7) 0.084b -
Sex of the newborn (boy) 51.0% (41.2% to 60.8%) 50.6% (40.4% to 60.7%) 0.95c -
Birth weight (grams) 3509 (3404 to 3615) 3507 (3417 to 3596) 0.97a -
Ponderal index (weight, kg/length, m3) 27.4 (26.9 to 27.9) 27.5 (27.0 to 27.9) 0.89a -
Large for gestational age 7.3% (3.6% to 14.3%) 5.6% (2.4% to 12.5%) 0.64c -
Small for gestational age 13.5% (8.1% to 21.8%) 6.7% (3.1% to 13.9%) 0.13c -
Exclusive breastfeeding (months) 3.0 (2.5 to 3.4) 2.8 (2.3 to 3.2) 0.52b 8, 0
aIndependent Samples T-test, bMann-Whitney U-test, cChi-Square Test, dFisher’s Exact Test; OGTT, oral glucose tolerance test (75 g glucose load, 2-hour);
cP = capillary plasma glucose; CI, confidence interval; *level of at least slightly out of breath; gw, gestational weeks.
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(Table 3) [43]. There were no differences in weight gain
velocity assessed as change in weight-for-length ≥ 0.67
SDS or ≤ −0.67 SDS between the groups. Because of the
lack of a Finnish age- and gender-adjusted BMI refer-
ence for children under two years of age, we could not
analyse BMI SDS. Absolute BMI was similar in the
groups at the ages of 0, 4, 6 and 12 months (Table 3).
Mixed effect linear regression models included group
and age of the child and interactions between group and
age of the child. Adding gender and the target height of
the child, mother’s pre-pregnancy BMI, smoking status
during pregnancy, number of pregnancies and mother’s
educational level to the models did not induce signifi-
cant differences to the results, and they were notincluded in the results reported. According to a mixed
effect linear regression model, the z-score slopes did not
differ significantly between the intervention and control
groups (p-value 0.71) (Table 4).
We performed post study power analysis for the differ-
ences in infants’ weight gain and found that the groups
should include 250 children when multilevel mixed-
effects linear regression model is used to analyse the as-
sociation of the weight-for-length z-score over time by
group.
Discussion
The results reported here suggest that the intervention
in this trial may have the potential to improve glucose
tolerance in pregnant mothers. According to earlier
Table 3 Anthropometric data in study groups during child’s first year (mean ± sd or frequency and %)
Intervention Control p-value Missing (n/group)
N 96 89
Weight-for-length SDS
0 months −0.08 ± 0.96 −0.07 ± 0.93 0.94a
4 months 0.05 ± 0.99 0.17 ± 1.10 0.46a
6 months 0.13 ± 1.02 0.20 ± 1.18 0.65a
12 months 0.09 ± 1.06 0.06 ± 1.11 0.85a 3, 0
Change in weight-for-length SDS
0 to 4 months 0.13 ± 1.17 0.24 ± 1.28 0.56b
0 to 6 months 0.21 ± 1.14 0.27 ± 1.38 0.74b
0 to 12 months 0.16 ± 1.20 0.14 ± 1.39 0.89b 3, 0
4 to 12 months 0.05 ± 0.90 −0.10 ± 0.74 0.21b 3, 0
6 to 12 months −0.02 ± 0.74 −0.14 ± 0.66 0.28b 3, 0
Change in weight-for-length SDS ≥ 0.67
0 to 4 months 32 (33.3%) 31 (34.8%) 0.83c
0 to 6 months 33 (34.4%) 36 (40.4%) 0.39c
0 to 12 months 32 (34.4%) 31 (34.8%) 0.95c 3, 0
4 to 12 months 20 (21.5%) 13 (14.6%) 0.23c 3, 0
6 to 12 months 13 (14.0%) 11 (12.4%) 0.75c 3, 0
Change in weight-for-length SDS ≤ − 0.67
0 to 4 months 25 (26.0%) 22 (24.7%) 0.84c
0 to 6 months 21 (21.9%) 23 (25.8%) 0.53c
0 to 12 months 23 (24.7%) 23 (25.8%) 0.86c 3, 0
4 to 12 months 23 (24.7%) 17 (19.1%) 0.36c 3, 0
6 to 12 months 21 (22.6%) 16 (18.0%) 0.44c 3, 0
Weight-for-length ≥ +10% e
0 months 9 (9.4%) 10 (11.2%) 0.68c
4 months 15 (15.6%) 18 (20.2%) 0.41c
6 months 15 (15.6%) 22 (24.7%) 0.12c
12 months 16 (17.2%) 18 (20.2%) 0.60c 3, 0
Weight-for-length > +20% f
0 months 1 (1.0%) 1 (1.1%) 1.00d
4 months 0 (0.0%) 4 (4.5%) 0.052d
6 months 4 (4.2%) 5 (5.6%) 0.74d
12 months 3 (3.2%) 1 (1.1%) 0.62d 3, 0
Body mass index (kg/m2)
0 months 13.8 ± 1.3 13.8 ± 1.1 0.93a
4 months 17.0 ± 1.4 17.2 ± 1.6 0.32a
6 months 17.4 ± 1.5 17.6 ± 1.7 0.58a
12 months 17.2 ± 1.4 17.2 ± 1.6 0.89a 3, 0
aIndependent Samples T-test, bLinear regression analysis, unadjusted, cChi-Square Test, dFisher’s Exact Test.
eassessed as overweight, fassessed as obese; SDS, standard deviation score.
Mustila et al. BMC Pediatrics 2013, 13:80 Page 7 of 11
http://www.biomedcentral.com/1471-2431/13/80studies a lower gestational glucose level can have a posi-
tive long-term effect in reducing the child’s risk of obes-
ity and type −2 diabetes [10,11,21]. The intervention did
not have a significant effect on mother’s weight gainduring pregnancy, although a slight tendency towards
lower weight gain was seen among the intervention group
mothers. No significant differences were found in the pro-
portions of non-complicated deliveries, offspring’s birth
Figure 1 Flow chart of the study. *Because of one year
retrospective recruitment.
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http://www.biomedcentral.com/1471-2431/13/80weight or ponderal index. Also, the duration of exclusive
breastfeeding was similar in both groups. Offspring
growth during the first year was not statistically signifi-
cantly different between the groups, but a slight tendency
was noted for the control group to have a higher propor-
tion of overweight offspring during the first year.
There is evidence of a favourable effect of lifestyle
counselling during pregnancy on mother’s diet, glucose
tolerance and foetal growth. Luoto et al. showed that
counselling on dietary and physical activity during preg-
nancy was effective in reducing the proportion of large-
for-age newborns [46]. They also showed that gestational
intervention had a beneficial effect on several dietary
aims, but only a non-significant effect on the increase inTable 4 Estimates and 95% confidence intervals for weight-fo
regression model
Weight-for-length SDS from 0 to 12 months of age Co
Group (intervention/control) −0
Age in months −0
Age in months 2 −0
Group * Age −0
SDS, standard deviation score; non-linear relationship between SDS and age of the
Age = interaction between age of the child and the group.physical activity [46]. Barakat et al. recently reported an
improvement in glucose tolerance in their physical activ-
ity intervention study during pregnancy [47]. We mea-
sured the mother’s physical activity by self-reports, and
no significant differences between the groups were
found. The control group’s physical activity was elicited
and recorded 1–12 months after the pregnancy, there-
fore, a recall bias cannot be excluded. Recall bias may
also affect the intervention group mothers’ estimates of
exercise taken, because the data was gathered only once
every trimester of pregnancy. Self-reports are also only
rough estimates of the time spent being physically active.
The incidence of GDM in Finland is estimated to be
close 11% according to the Medical Birth Register for
2004–2006 [48]. A fourth of overweight pregnant women
have been estimated to get GDM. In the study by Luoto
et al. a third of women in comparable risk group as ours
got GDM [46]. The lower proportion of pathological
OGTT results at 26–28 gestational weeks in the interven-
tion group could be attributable to dietary changes. Since
our main and secondary outcomes are the offspring’s mea-
sures, we did not keep any dietary records during preg-
nancy, but only started to gather these during the toddler
years. An increase in fibre-rich food intake, which was one
of the aims of the counselling, has the potential to im-
prove glucose tolerance. Differences in energy consump-
tions between the groups seems more unlikely since there
were only indicative differences between weight gain dur-
ing pregnancy and no significant differences in self-
reported physical activity. The first group intervention was
offered not later than at 20 gestational weeks’ and the
PHNs gave intensive counselling at mothers’ routine visits
to maternity clinics beginning from 10 to 12 gestational
weeks, making it possible that the intervention may have
had an ameliorating effect on the OGTT results. The
mothers were told that their lifestyle during pregnancy
could have significant effects on the outcomes of the preg-
nancy and on their newborns, and also on the offspring’s
weight development. We believe that this knowledge may
have motivated the intervention mothers to make healthy
dietary changes during pregnancy.
Mothers with abnormal OGTT results suggesting
GDM and thereafter also abnormal plasma glucoser-length SDS from multilevel mixed-effects linear
efficient 95% CI p-value
.71 −0.31 to 0.16 0.56
.06 0.02 to 0.01 0.002
.004 −0.007 to −0.002 0.002
.006 −0.023 to 0.034 0.71
child was modelled using polynomial age in months 2; Group *
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http://www.biomedcentral.com/1471-2431/13/80values in self-monitoring are referred to the central hos-
pital for further assessment and treatment. All mothers
with GDM are given dietary advice contributing to bet-
ter glucose balance and a glucose meter to monitor their
glucose values at home. Insulin treatment is initiated if the
target glucose balance is not achieved by these means. The
effective treatment of GDM may have had an impact on
the outcomes we measured: GWG, type of delivery and
newborn weight. This could at least in part explain why
there were no significant differences in these measures des-
pite the higher prevalence of GDM among the control
group mothers. There were no significant differences in the
newborns’ birth weights, but it has been shown that the risk
of giving birth to a macrosomic baby is related to mother’s
BMI before pregnancy, when her GDM is well controlled
[49]. Despite the lack of statistical significance, the some-
what lower gestational weight gain until 37 weeks of gesta-
tion according to confidence intervals, may be a result of
the intervention and partly explain the lower incidence of
GDM in the intervention group. It is also possible that the
higher prevalence of GDM in the control group is a biased
result from the insufficient power of the sample, type 1
error or a chance.
The offspring’s weight-for-length was analysed and ad-
justed with the recently updated Finnish growth refer-
ence to obtain the SDS [43]. Weight gain velocity was
analysed by assessing the proportions of infants whose
change in weight-for-length was at least 0.67 SDS during
their first 12 months. A weight-for-age difference of
>0.67 SD has been defined as a clinically relevant rapid
weight gain in infancy associated with a risk of obesity
later in childhood [14]. Weight gain during infancy was
analysed with mixed effect models allowing for a differ-
ence between groups at baseline, changes over time and
intervention effects. No significant differences were
found between the intervention and control group off-
spring’s weight gain during the first year of life. The
intervention did not result in a longer duration of exclu-
sive breastfeeding, which may result from the very light
intervention in this issue. Improvements in foetal condi-
tions such as mothers’ lower glucose level during preg-
nancy have been shown to have no positive effect on the
offspring’s weight gain until the toddler years [9,10,19].
These above mentioned facts could explain why no dif-
ferences in infant weight gains were seen despite the dif-
ferences in mothers’ glucose tolerance in mid-pregnancy.
The total drop-out rate among the intervention group
during pregnancy was 22% (Figure 1). The most common
reasons for dropping-out were an early miscarriage or the
mother finding the study intervention too taxing. The mis-
carriages occurred during the first trimester of the pregnan-
cies (except for one registered in the 20th gestational week),
excluding the effect of the intervention on miscarriage rate.
High drop-out rate is usual in lifestyle interventions and inthat regard the drop-out rate in our study during pregnancy
is moderate. It is possible that the mothers who were most
motivated to make lifestyle changes and at the lowest risk
for GDM were the ones who continued in the intervention.
This could have had an impact on GDM prevalence results
in the groups.
The study groups were comparable at baseline as char-
acteristics possibly interfering in the offspring’s risk of
obesity showed no statistically significant differences be-
tween the groups. However, we were not able to obtain
reliable data on the mothers’ possible previous GDM.
We targeted a group of mothers at risk of developing
GDM, thus making the possibility of the intervention ef-
fect higher. The intervention was started during foetal
and infant life, which are the periods known to be risk
periods for the future development of obesity.
Our study has several limitations. It is not randomised
and the control group was up to one year retrospective
concerning outcomes in pregnancy, which could cause
some bias in the results. The public health physiotherap-
ist, dietician and maternity clinic PHNs only cared for
the intervention group mothers, and the control group
mothers’ and infants’ data was gathered when the con-
trol offspring was one year of age, that is one year before
intervention was started, removing a possible Hawthorn
effect on the control group.
The participation rate in the group counselling sessions
during pregnancy was good, although it was lower in the
second session. Almost 98% of the mothers in Finland avail
themselves of the planned routine visits to municipal ma-
ternity health care. Thus, the risk mothers are more effect-
ively reached if the intensified counselling is arranged in
connection with these routine visits, which was partly the
case in our study.
Some of the public health nurses particularly felt that the
recruitment of the intervention group and the paperwork
of the study were burdensome, mostly because of their hec-
tic pace of work. This may have attenuated the success of
recruiting in some maternity clinics. The motivation of the
PHNs to perform intensive counselling may have varied,
making the intervention uneven. However, this is common
in real life implementations and the results are in this re-
spect comparable to these settings. Implementation in real-
life practice has good potential to be a sustainable part of
municipal health care if proved to be effective. The mater-
nity and child health care clinics have a good opportunity
to reach the risk population for childhood obesity during a
life phase when the families are motivated to make changes
in their behaviour in order to promote their offspring’s
health.
Conclusions
Obesity with its great health and economic burden chal-
lenges society to initiate preventive actions. The most
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http://www.biomedcentral.com/1471-2431/13/80natural setting in primary health care for preventive in-
terventions is maternity and child health care clinics, as
this reaches the beginning of next generation. To find ef-
fective prevention programmes pragmatic trials in the
real-life setting are needed. Our study appeared to im-
prove glucose tolerance during pregnancy, suggesting its
potential to have a positive effect on offspring weight
gain. We failed to find any effect on newborn birth
weight or infant weight gain, but research has shown
that an adverse effect of gestational diabetes on the off-
spring’s weight gain tends to develop only later in child-
hood. Several ongoing early life intervention studies to
prevent childhood obesity will provide more evidence
on the feasibility of programmes for implementing in
practice, including our intervention and follow-up con-
tinuing in child health care centres during preschool
years.
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